The effects of hyaluronidase on coronary blood flow following coronary artery occlusion in the dog

J. Askenazi, L. D. Hillis, P. E. Diaz, M. A. Davis, E. Braunwald, P. R. Maroko

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

In an attempt to determine the mechanism by which hyaluronidase reduces myocardial injury following coronary artery occlusion, myocardial blood flow was studied in 20 open chest dogs with occlusion of the left anterior descending coronary artery. Ten dogs served as controls, and 10 received hyaluronidase (500 NF units/kg) intravenously 20 minutes after occlusion. At 15 minutes and at 6 hours after occlusion, regional myocardial blood flow in the epicardial and endocardial halves of both ischemic and nonischemic zones were determined with radiolabeled microspheres. Mean arterial pressure, heart rate, and cardiac output were similar in the untreated and treated dogs through the 6 hours of the experiment. Moreover, regional blood flow to nonischemic myocardium (areas without epicardial S-T segment elevation 15 minutes after occlusion) was similar in the two groups 15 minutes and 6 hours after occlusion. Fifteen minutes after occlusion, the flow to the ischemic myocardium subjacent to sites with S-T segment elevation exceeding 2 mV) in the untreated group was: transmural, 28.1 ±2.2 (mean ± SE) ml/min per 100 g; endocardial, 20.7 ± 1.8; and epicardial 38.5 ± 3.1. The endocardial epicardial flow ratio was 0.56 ± 0.04. Six hours after occlusion, the untreated group demonstrated a further decrease in blood flow to the ischemic myocardium: transmural, 15.2 ± 1.4 ml/min per 100 g; endocardial, 6.8 ± 1.1; and epicardial, 24.3 ± 1.9. The endocardial epicardial flow ratio fell to 0.28 ± 0.04. In contrast, the hyaluronidase treated dogs showed no further reductin in blood flow to ischemic myocardium 6 hours after occlusion: transmural, 30.3 ± 3.1 ml/min per 100 g; endocardial, 21.3 ± 2.5; and epicardial, 38.8 ± 3.8. These regional myocardial flows were significantly higher than those of the untreated dogs 6 hours after occlusion. Thus, salvage or damaged myocardium by hyaluronidase might be explained by its beneficial effect on collateral blood flow to the ischemic tissue, though this effect on collateral flow could be the consequence rather than the cause of this salvage.

Original languageEnglish (US)
Pages (from-to)566-571
Number of pages6
JournalCirculation Research
Volume40
Issue number6
StatePublished - 1977
Externally publishedYes

Fingerprint

Hyaluronoglucosaminidase
Coronary Occlusion
Coronary Vessels
Myocardium
Dogs
Regional Blood Flow
Microspheres
Cardiac Output
Arterial Pressure
Thorax
Heart Rate
Wounds and Injuries

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Askenazi, J., Hillis, L. D., Diaz, P. E., Davis, M. A., Braunwald, E., & Maroko, P. R. (1977). The effects of hyaluronidase on coronary blood flow following coronary artery occlusion in the dog. Circulation Research, 40(6), 566-571.

The effects of hyaluronidase on coronary blood flow following coronary artery occlusion in the dog. / Askenazi, J.; Hillis, L. D.; Diaz, P. E.; Davis, M. A.; Braunwald, E.; Maroko, P. R.

In: Circulation Research, Vol. 40, No. 6, 1977, p. 566-571.

Research output: Contribution to journalArticle

Askenazi, J, Hillis, LD, Diaz, PE, Davis, MA, Braunwald, E & Maroko, PR 1977, 'The effects of hyaluronidase on coronary blood flow following coronary artery occlusion in the dog', Circulation Research, vol. 40, no. 6, pp. 566-571.
Askenazi J, Hillis LD, Diaz PE, Davis MA, Braunwald E, Maroko PR. The effects of hyaluronidase on coronary blood flow following coronary artery occlusion in the dog. Circulation Research. 1977;40(6):566-571.
Askenazi, J. ; Hillis, L. D. ; Diaz, P. E. ; Davis, M. A. ; Braunwald, E. ; Maroko, P. R. / The effects of hyaluronidase on coronary blood flow following coronary artery occlusion in the dog. In: Circulation Research. 1977 ; Vol. 40, No. 6. pp. 566-571.
@article{8b251ca87204472eaeac566c62a6b5d6,
title = "The effects of hyaluronidase on coronary blood flow following coronary artery occlusion in the dog",
abstract = "In an attempt to determine the mechanism by which hyaluronidase reduces myocardial injury following coronary artery occlusion, myocardial blood flow was studied in 20 open chest dogs with occlusion of the left anterior descending coronary artery. Ten dogs served as controls, and 10 received hyaluronidase (500 NF units/kg) intravenously 20 minutes after occlusion. At 15 minutes and at 6 hours after occlusion, regional myocardial blood flow in the epicardial and endocardial halves of both ischemic and nonischemic zones were determined with radiolabeled microspheres. Mean arterial pressure, heart rate, and cardiac output were similar in the untreated and treated dogs through the 6 hours of the experiment. Moreover, regional blood flow to nonischemic myocardium (areas without epicardial S-T segment elevation 15 minutes after occlusion) was similar in the two groups 15 minutes and 6 hours after occlusion. Fifteen minutes after occlusion, the flow to the ischemic myocardium subjacent to sites with S-T segment elevation exceeding 2 mV) in the untreated group was: transmural, 28.1 ±2.2 (mean ± SE) ml/min per 100 g; endocardial, 20.7 ± 1.8; and epicardial 38.5 ± 3.1. The endocardial epicardial flow ratio was 0.56 ± 0.04. Six hours after occlusion, the untreated group demonstrated a further decrease in blood flow to the ischemic myocardium: transmural, 15.2 ± 1.4 ml/min per 100 g; endocardial, 6.8 ± 1.1; and epicardial, 24.3 ± 1.9. The endocardial epicardial flow ratio fell to 0.28 ± 0.04. In contrast, the hyaluronidase treated dogs showed no further reductin in blood flow to ischemic myocardium 6 hours after occlusion: transmural, 30.3 ± 3.1 ml/min per 100 g; endocardial, 21.3 ± 2.5; and epicardial, 38.8 ± 3.8. These regional myocardial flows were significantly higher than those of the untreated dogs 6 hours after occlusion. Thus, salvage or damaged myocardium by hyaluronidase might be explained by its beneficial effect on collateral blood flow to the ischemic tissue, though this effect on collateral flow could be the consequence rather than the cause of this salvage.",
author = "J. Askenazi and Hillis, {L. D.} and Diaz, {P. E.} and Davis, {M. A.} and E. Braunwald and Maroko, {P. R.}",
year = "1977",
language = "English (US)",
volume = "40",
pages = "566--571",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - The effects of hyaluronidase on coronary blood flow following coronary artery occlusion in the dog

AU - Askenazi, J.

AU - Hillis, L. D.

AU - Diaz, P. E.

AU - Davis, M. A.

AU - Braunwald, E.

AU - Maroko, P. R.

PY - 1977

Y1 - 1977

N2 - In an attempt to determine the mechanism by which hyaluronidase reduces myocardial injury following coronary artery occlusion, myocardial blood flow was studied in 20 open chest dogs with occlusion of the left anterior descending coronary artery. Ten dogs served as controls, and 10 received hyaluronidase (500 NF units/kg) intravenously 20 minutes after occlusion. At 15 minutes and at 6 hours after occlusion, regional myocardial blood flow in the epicardial and endocardial halves of both ischemic and nonischemic zones were determined with radiolabeled microspheres. Mean arterial pressure, heart rate, and cardiac output were similar in the untreated and treated dogs through the 6 hours of the experiment. Moreover, regional blood flow to nonischemic myocardium (areas without epicardial S-T segment elevation 15 minutes after occlusion) was similar in the two groups 15 minutes and 6 hours after occlusion. Fifteen minutes after occlusion, the flow to the ischemic myocardium subjacent to sites with S-T segment elevation exceeding 2 mV) in the untreated group was: transmural, 28.1 ±2.2 (mean ± SE) ml/min per 100 g; endocardial, 20.7 ± 1.8; and epicardial 38.5 ± 3.1. The endocardial epicardial flow ratio was 0.56 ± 0.04. Six hours after occlusion, the untreated group demonstrated a further decrease in blood flow to the ischemic myocardium: transmural, 15.2 ± 1.4 ml/min per 100 g; endocardial, 6.8 ± 1.1; and epicardial, 24.3 ± 1.9. The endocardial epicardial flow ratio fell to 0.28 ± 0.04. In contrast, the hyaluronidase treated dogs showed no further reductin in blood flow to ischemic myocardium 6 hours after occlusion: transmural, 30.3 ± 3.1 ml/min per 100 g; endocardial, 21.3 ± 2.5; and epicardial, 38.8 ± 3.8. These regional myocardial flows were significantly higher than those of the untreated dogs 6 hours after occlusion. Thus, salvage or damaged myocardium by hyaluronidase might be explained by its beneficial effect on collateral blood flow to the ischemic tissue, though this effect on collateral flow could be the consequence rather than the cause of this salvage.

AB - In an attempt to determine the mechanism by which hyaluronidase reduces myocardial injury following coronary artery occlusion, myocardial blood flow was studied in 20 open chest dogs with occlusion of the left anterior descending coronary artery. Ten dogs served as controls, and 10 received hyaluronidase (500 NF units/kg) intravenously 20 minutes after occlusion. At 15 minutes and at 6 hours after occlusion, regional myocardial blood flow in the epicardial and endocardial halves of both ischemic and nonischemic zones were determined with radiolabeled microspheres. Mean arterial pressure, heart rate, and cardiac output were similar in the untreated and treated dogs through the 6 hours of the experiment. Moreover, regional blood flow to nonischemic myocardium (areas without epicardial S-T segment elevation 15 minutes after occlusion) was similar in the two groups 15 minutes and 6 hours after occlusion. Fifteen minutes after occlusion, the flow to the ischemic myocardium subjacent to sites with S-T segment elevation exceeding 2 mV) in the untreated group was: transmural, 28.1 ±2.2 (mean ± SE) ml/min per 100 g; endocardial, 20.7 ± 1.8; and epicardial 38.5 ± 3.1. The endocardial epicardial flow ratio was 0.56 ± 0.04. Six hours after occlusion, the untreated group demonstrated a further decrease in blood flow to the ischemic myocardium: transmural, 15.2 ± 1.4 ml/min per 100 g; endocardial, 6.8 ± 1.1; and epicardial, 24.3 ± 1.9. The endocardial epicardial flow ratio fell to 0.28 ± 0.04. In contrast, the hyaluronidase treated dogs showed no further reductin in blood flow to ischemic myocardium 6 hours after occlusion: transmural, 30.3 ± 3.1 ml/min per 100 g; endocardial, 21.3 ± 2.5; and epicardial, 38.8 ± 3.8. These regional myocardial flows were significantly higher than those of the untreated dogs 6 hours after occlusion. Thus, salvage or damaged myocardium by hyaluronidase might be explained by its beneficial effect on collateral blood flow to the ischemic tissue, though this effect on collateral flow could be the consequence rather than the cause of this salvage.

UR - http://www.scopus.com/inward/record.url?scp=0017646875&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017646875&partnerID=8YFLogxK

M3 - Article

C2 - 870237

AN - SCOPUS:0017646875

VL - 40

SP - 566

EP - 571

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 6

ER -